Home LiteratureArticle Details
PMID: 11809805 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Atypical protein kinase Cs are the Ras effectors that mediate repression of myogenic satellite cell differentiation.

Molecular and cellular biology ·Vol. 22 ·No. 4 ·2002-02-00 ·Pages 1140-9

Fedorov YV, Jones NC, Olwin BB

Abstract

Oncogenic Ha-Ras is a potent inhibitor of skeletal muscle cell differentiation, yet the Ras effector mediating this process remains unidentified. Here we demonstrate that the atypical protein kinases (aPKCs; lambda and/or zeta) are downstream Ras effectors responsible for Ras-dependent inhibition of myogenic differentiation in a satellite cell line. First, ectopic expression of Ha-RasG12V induces translocation of PKClambda from the cytosol to the nucleus, suggesting that aPKCs are activated by Ras in myoblasts. The aPKCs function as downstream Ras effectors since inhibition of aPKCs by expression of a dominant negative PKCzeta mutant or by treatment of cells with an inhibitor, GO6983, promotes myogenesis in skeletal muscle satellite cells expressing oncogenic Ha-Ras. Arresting cell proliferation synergistically enhances myogenic differentiation only when aPKCs are also inhibited. Thus, the repression of myogenic differentiation in a satellite cell line appears to be directly mediated by aPKCs acting as Ras effectors and indirectly mediated via stimulation of cell proliferation.

MeSH Terms
Animals Butadienes/pharmacology Carbazoles/pharmacology Cell Differentiation Cell Division/physiology Cell Line Enzyme Inhibitors/pharmacology Genes, Reporter Immunohistochemistry Indoles/pharmacology Isoenzymes/genetics,metabolism Mice Mitogen-Activated Protein Kinases/antagonists & inhibitors,metabolism Muscle Development Muscle, Skeletal/cytology,drug effects,growth & development,physiology Nitriles/pharmacology Protein Kinase C/antagonists & inhibitors,genetics,metabolism Transfection ras Proteins/metabolism
Chemicals
Butadienes Carbazoles Enzyme Inhibitors Indoles Isoenzymes Nitriles U 0126 Go 6976 Protein Kinase C Mitogen-Activated Protein Kinases ras Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Fedorov Yuri V
Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado 80309, USA.
Jones Nathan C
Olwin Bradley B
References (34)
34 references, click to expand
  1. Multiple Ras functions can contribute to mammalian cell transformation.
    Cell. 1995 Feb 24;80(4):533-41 PMID: 7867061
  2. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta.
    J Biol Chem. 1994 Dec 16;269(50):31706-10 PMID: 7989344
  3. A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways.
    Mol Cell Biol. 1995 Jun;15(6):3238-46 PMID: 7760819
  4. Overexpression of mammalian protein kinase C-zeta does not affect the growth characteristics of NIH 3T3 cells.
    Biochem Biophys Res Commun. 1995 Aug 4;213(1):266-72 PMID: 7639744
  5. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
    Mol Cell Biol. 1996 Jul;16(7):3923-33 PMID: 8668210
  6. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes.
    FEBS Lett. 1996 Aug 26;392(2):77-80 PMID: 8772178
  7. Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis.
    Mol Cell Biol. 1997 Jul;17(7):3547-55 PMID: 9199290
  8. MEKK1 binds directly to the c-Jun N-terminal kinases/stress-activated protein kinases.
    J Biol Chem. 1997 Dec 19;272(51):32056-60 PMID: 9405400
  9. A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis.
    J Biol Chem. 1998 Jul 10;273(28):17696-701 PMID: 9651367
  10. The FGF receptor-1 tyrosine kinase domain regulates myogenesis but is not sufficient to stimulate proliferation.
    J Cell Biol. 1998 Jul 13;142(1):241-50 PMID: 9660877
  11. Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta.
    EMBO J. 1998 Jul 15;17(14):4046-55 PMID: 9670019
  12. The broad specificity of dominant inhibitory protein kinase C mutants infers a common step in phosphorylation.
    Biochem J. 1998 Aug 1;333 ( Pt 3):631-6 PMID: 9677322
  13. Regulation of myogenesis by fibroblast growth factors requires beta-gamma subunits of pertussis toxin-sensitive G proteins.
    Mol Cell Biol. 1998 Oct;18(10):5780-7 PMID: 9742095
  14. Increasing complexity of Ras signaling.
    Oncogene. 1998 Sep 17;17(11 Reviews):1395-413 PMID: 9779987
  15. Effects of transiently expressed atypical (zeta, lambda), conventional (alpha, beta) and novel (delta, epsilon) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-zeta and C-lambda.
    Biochem J. 1999 Feb 1;337 ( Pt 3):461-70 PMID: 9895289
  16. Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton.
    J Cell Biol. 1999 Feb 8;144(3):413-25 PMID: 9971737
  17. Association of atypical protein kinase C isotypes with the docker protein FRS2 in fibroblast growth factor signaling.
    J Biol Chem. 1999 Jul 2;274(27):19025-34 PMID: 10383403
  18. Loss of FGF receptor 1 signaling reduces skeletal muscle mass and disrupts myofiber organization in the developing limb.
    Dev Biol. 2000 Feb 1;218(1):21-37 PMID: 10644408
  19. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion.
    J Cell Physiol. 2001 Jan;186(1):104-15 PMID: 11147804
  20. Oncogenic Ras-induced proliferation requires autocrine fibroblast growth factor 2 signaling in skeletal muscle cells.
    J Cell Biol. 2001 Mar 19;152(6):1301-5 PMID: 11257129
  21. Differential effects of Ras signaling through NFkappaB on skeletal myogenesis.
    Oncogene. 2001 Mar 15;20(11):1276-86 PMID: 11313872
  22. Control of mouse myoblast commitment to terminal differentiation by mitogens.
    J Supramol Struct. 1980;14(4):483-98 PMID: 6454029
  23. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.
    EMBO J. 1986 Dec 1;5(12):3133-42 PMID: 3102226
  24. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation.
    Mol Cell Biol. 1987 Jun;7(6):2104-11 PMID: 3600660
  25. Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor.
    J Cell Biol. 1987 Aug;105(2):949-56 PMID: 3624313
  26. Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene.
    Oncogene. 1989 Apr;4(4):473-81 PMID: 2654809
  27. Retention of specific protein kinase C isozymes following chronic phorbol ester treatment in BC3H-1 myocytes.
    Biochem Biophys Res Commun. 1989 May 30;161(1):327-34 PMID: 2730662
  28. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.
    Cancer Res. 1989 Nov 15;49(22):6324-7 PMID: 2680062
  29. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.
    J Biol Chem. 1991 Aug 25;266(24):15771-81 PMID: 1874734
  30. Evidence for a role of protein kinase C zeta subspecies in maturation of Xenopus laevis oocytes.
    Mol Cell Biol. 1992 Sep;12(9):3776-83 PMID: 1508183
  31. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C.
    Science. 1992 Oct 23;258(5082):607-14 PMID: 1411571
  32. Protein kinase C zeta isoform is critical for mitogenic signal transduction.
    Cell. 1993 Aug 13;74(3):555-63 PMID: 7688666
  33. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.
    J Cell Biol. 1994 Jun;125(6):1275-87 PMID: 8207057
  34. Protein kinase C and lipid signaling for sustained cellular responses.
    FASEB J. 1995 Apr;9(7):484-96 PMID: 7737456
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2002-02-00
Pages
1140-9
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC134628
Subset
IM
Grants
NIAMS NIH HHS · R01 AR039467 · United States
NIAMS NIH HHS · AR39467 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]